U S Physical Therapy (USPH) Current Deferred Revenue (2025 - 2026)
U S Physical Therapy's (USPH) quarterly Current Deferred Revenue came in at $753000.0 in Q2 2026, down 26.89% quarter-over-quarter from $1.0 million in Q1 2026.
Powered by 
Analysis
U S Physical Therapy (USPH) Current Deferred Revenue (2025 - 2026) Analysis & Trends
U S Physical Therapy has disclosed Current Deferred Revenue across 2 years of filings, most recently posting $753000.0 for Q2 2026.
- In Q2 2026, Current Deferred Revenue changed N/A year-over-year to $753000.0; the TTM figure through Jun 2026 stood at $753000.0 (changed N/A YoY), while the FY2025 annual figure was $737000.0, changed N/A from the prior year.
- Current Deferred Revenue came in at $753000.0 for Q2 2026 at U S Physical Therapy, down from $1.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.0 million in Q1 2026 to a low of $737000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.64 Bn | 1.16 Bn |
| 2 | RadNet | 5.80 Bn | 5.37 Bn | 88.08 Mn |
| 3 | Concentra Group Holdings Parent | 4.40 Bn | 4.26 Bn | 192.10 Mn |
| 4 | Privia Health | 2.61 Bn | 2.25 Bn | - |
| 5 | Pediatrix Medical | 2.20 Bn | 1.79 Bn | - |
| 6 | Fresenius Medical Care AG | 2.11 Bn | 1.41 Bn | 1.52 Bn |
| 7 | Progyny | 2.01 Bn | 1.77 Bn | 89.30 Mn |
| 8 | Surgery Partners | 1.87 Bn | 3.08 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.18 Bn | 1.47 Bn | 41.94 Mn |
| 10 | Starling Oncology | 595.78 Mn | 554.69 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 753,000.00 |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 737,000.00 |